Cambrooke continues to build a robust pipeline of unique therapeutic nutrition products in a wide array of clinical areas. Cambrooke prioritizes its research and development efforts in areas of metabolic diseases. We are developing the medical nutritional solutions that will matter most to the people we serve.
Special emphasis in orphan and genetic diseases illustrate and define our dedication to develop and deliver innovative medical nutrition therapies that will benefit our patients around the world.
We continue to partner with others to access the best science and accelerate the development of new medical nutrition therapies to move our pipeline candidates from clinical development into commercial applications. Innovation and a commitment to scientific excellence is the standard for excellence at Cambrooke Therapeutics.